Radiation-induced DNA damage and repair in human γδ and αβ T-lymphocytes analysed by the alkaline comet assay

2041-9414-1-8 2041-9414 Research Radiation-induced DNA damage and repair in human γδ and αβ T-lymphocytes analysed by the alkaline comet assay LisowskaHalinahalina.lisowska@gmail.com Deperas-KaminskaMartamarta-deperas@tlen.pl HaghdoostSiamaksiamak.haghdoost@gmt.su.se ParmrydIngelaingela.parmryd@wgi.su.se WojcikAndrzejandrzej.wojcik@gmt.su.se

Jan Kochanowski University, Department of Radiobiology and Immunology, Kielce, Poland

Joint Institute for Nuclear Research, Dubna, Russia

Department of Genetics Microbiology and Toxicology, Stockholm University, Sweden

The Wenner-Gren Institute, Stockholm University, Sweden

Genome Integrity 2041-9414 2010 1 1 8 http://www.genomeintegrity.com/content/1/1/8 2067825810.1186/2041-9414-1-8 28420108620108620102010Lisowska et al; licensee BioMed Central Ltd.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

It has been shown by a number of authors that the radiosensitivity of peripheral blood mononuclear cells (PBMC) is higher in cancer patients compared to healthy donors, which is interpreted as a sign of genomic instability. PBMC are composed of different cell subpopulations which are differently radiosensitive and the difference between cancer patients and healthy donors could also be due to different composition of their PBMC pools. Gamma-delta T-lymphocytes play an important role in immunosurveillance and are promising cells for immunotherapy. Their abundance is frequently reduced in cancer patients so should their sensitivity to radiation be lower than that of other T-lymphocytes, this could, at least partly explain the low radiosensitivity of PBMC from healthy individuals compared to cancer patients. The present investigation was carried out to test this. Using the alkaline comet assay we analysed the level of DNA damage and repair in isolated γδ T-lymphocytes, pan T-lymphocytes and in total PBMC exposed in vitro to gamma radiation. We found no difference in the level of DNA damage and the capacity of DNA repair between the T cell populations. This is the first study that addresses the question of sensitivity to radiation of gamma-delta T-cells.

Background

Human peripheral blood mononuclear cells (PBMC) are used as surrogate tissue for the assessment of individual sensitivity to ionising radiation 1. Using the G₂chromosomal aberration assay it has been shown by a number of authors that the radiosensitivity of PBMC is higher in cancer patients compared to healthy donors 23456789. A similar result was reported using the micronucleus assay 10 and the comet assay 1112 and is generally interpreted as a reflection of genomic instability in PBMC of cancer patients 10.

PBMC are composed of different cell subpopulations which are differently radiosensitive. It is generally accepted that B lymphocytes show a higher radiosensitivity than T-lymphocytes that are all CD3+ 13141516. Among the T-lymphocytes cytotoxic CD8+ cells appear somewhat more sensitive than helper CD4+ cells 1617, although this was not observed in all studies 18. A lymphocyte subpopulation which recently attracted interest is composed of T-lymphocytes with γδ T-cell receptors (TCR). The reason for this is the discovery that these cells contribute to immunity against cancer 19. In peripheral blood γδ lymphocytes account for less than 5% of total T-lymphocytes while their proportion in the intestine can be much higher 20.

Given their role in immunosurveillance, the level and/or the activity of γδ T-lymphocytes is expected to be low in PBMC of cancer-prone individuals and high in PBMC of individuals who are resistant to cancer. This is supported by findings in patients with lymphoma, myeloma, breast and nasopharyngeal carcinoma 212223. Should the sensitivity to radiation of γδ lymphocytes be lower than that of the more common αβ T-lymphocytes, this could, at least partly explain the low radiosensitivity of PBMC from healthy individuals compared to cancer patients. The present investigation was carried out to test if there are differences in the radiation sensitivity between different TCR subtype populations by comparing the level of DNA damage and the kinetics of DNA repair in isolated γδ T-lymphocytes, pan T-lymphocytes and in total PBMC exposed in vitro to gamma radiation. Experiments were performed using the alkaline comet assay. Cells were exposed to the moderate dose of 1 Gy at 37°C.

Results

We decided to analyse the percentage of DNA in the tail (% TDNA) as marker of damage 24. The control % TDNA values did not differ significantly between 0 and 60 min of incubation at 37°C (Figure 1). The average level of spontaneous damage was highest in γδ T-lymphocytes and it was significantly higher than in pan T-lymphocytes. The differences between γδ T-lymphocytes and PBMC, as well as between pan T-lymphocytes and PBMC were not significant.

Figure 1

Spontaneous levels of DNA damage measured after 0 min and 60 min of incubation time

Spontaneous levels of DNA damage measured after 0 min and 60 min of incubation time. Error bars: standard deviations from the mean % TDNA values. PT: pan T, GD: gamma-delta, PBMC: peripheral blood mononuclear cells, ns: non significant.

The % TDNA values found in the control cells were subtracted from the radiation-induced values. The net radiation-induced % TDNA values as a function of repair time are shown in figure 2. No consistent difference between the cell subpopulations was observed for the initial level of DNA damage. DNA repair proceeded in all cell types at a similar rate and following 60 min of repair the majority of DNA damage was repaired. No consistent difference between the cell subpopulations was observed for the residual level damage.

Figure 2

Kinetics of DNA repair in cells from three independent experiments each with with lymphocytes of one donor donor (panels A-C) and pooled results (panel D)

Kinetics of DNA repair in cells from three independent experiments each with with lymphocytes of one donor donor (panels A-C) and pooled results (panel D). Net percent of DNA in tail values are shown. Error bars: standard deviations from individual cell measurements (panels A-C) and from the mean % TDNA values (panel D). PT: pan T, GD: gamma-delta, PBMC: peripheral blood mononuclear cells.

An advantage of the comet assay is the ability to analyse DNA damage in individual cells. Although we observed no difference in the mean level of DNA damage between the analysed cell subpopulations, it is possible that differences existed in the distribution patterns of cells with different level of DNA damage. In order to check this, cells were grouped into classes of % TDNA values and plotted on one graph. The results for 0 and 60 min repair are shown in figure 3. The distribution patterns of all three cell populations look similar.

Figure 3

Distributions of comets scored after 0 min repair (initial damage - panel A) and 60 min repair (residual damage - panel B)

Distributions of comets scored after 0 min repair (initial damage - panel A) and 60 min repair (residual damage - panel B). Cells were grouped into classes of percent of DNA in tail values. Pooled results from three experiments. Error bars: standard deviations from independent experiments. PT: pan T, GD: gamma-delta, PBMC: peripheral blood mononuclear cells.

Discussion

It has been proposed that the in vitro radiosensitivity of PBMC correlates with individual sensitivity to ionising radiation 1 and it has been shown that the in vitro radiosensitivity of PBMC is higher in cancer patients compared to healthy donors 23456789101112. The mechanisms behind these observations are not known. One factor could be a different composition of lymphocyte subsets in PBMC collected for analysis from radiosensitive and radioresistant donors.

Differences in the radiosensitivity of lymphocyte subsets have been demonstrated, although the results are contradictory. A high sensitivity of B-, as compared to T-lymphocytes has generally been found (see 1416 and the literature within), whereas one study found no difference between the subsets after high doses of gamma radiation and after exposure of cells to neutrons 15. Both Wilkins et al. 17 and Schmitz et al. 16 observed a somewhat higher sensitivity in CD8+ than in CD4+ T-lymphocytes. No difference between CD8+ and CD4+ T-lymphocytes was observed by Louagie at al. 18, who however, found that both CD8+ and CD4+ T-cells were more radiosensitive than NK cells. In these studies, αβ and γδ T-cells were not separated meaning that the bulk of both CD8+ and CD4+ T-lymphocytes would have had the αβ receptor. We have, for the first time, compared the radiosensitivity of γδ T-lymphocytes with that of pan T-lymphocytes and PBMC. Pan T-lymphocytes are composed of both αβ and γδ T-lymphocytes, however, the fraction of the latter in lymphocytes of our donors was not higher than 3% (not shown), so their influence on the radiosensitivity of pan T-lymphocytes is negligible. We found no difference in the level of radiation-induced DNA damage and the capacity of DNA repair between the cell populations.

Our result shows that the low radiosensitivity of PBMC isolated from healthy donors compared to cancer patients, can not be due to a high level of γδ T-lymphocytes in the peripheral blood of the former. This does not exclude the possibility that the difference in radiosensitivity results from a different composition of lymphocyte subpopulations in healthy and cancer patients. However, this possibility has hitherto not been studied.

An interesting finding was that the level of spontaneous DNA damage was higher in γδ T-lymphocytes than in pan T-lymphocytes and in PBMC. This finding is somewhat difficult to interpret. The essential factor determining whether a segment of DNA appears in the tail rather than in the head of a comet is the relaxation of DNA supercoiling which is a consequence of DNA damage 24. This would suggest that γδ T-lymphocytes suffer from a high level of spontaneous DNA damage. The reason for this is unclear and in our opinion the result should be treated with caution. Obviously, it must be validated by more studies.

An observation that requires a comment is the large scatter of the comet results as seen in figure 2. We scored the slides in a blind manner and the large standard deviations are due to the presence of both intact and damaged cells on the same slide. We tried to reduce the scatter by eliminating from analysis an equal number of cells with lowest and highest level of damage, but the standard deviations remained broad. A lower scatter would possibly be found if we used a higher dose of radiation than 1 Gy. This would lead to a higher level of DNA damage. However, we intentionally kept the dose at 1 Gy, because of the known high radiosensitivity of some lymphocyte subsets 25. In our opinion a dose higher than 1 Gy could have damaged the lymphocytes to an extent that would make the results unreliable.

It should be stressed that despite our negative results related to the sensitivity of cells to radiation, γδ T-lymphocytes, in particular those having the γ9δ2 TCR, are interesting cells to exploit for immunotherapy because they specifically cause lysis of tumour cells without affecting non transformed cells 26 and clinical trials show promising results with γδ T lymphocyte immunotherapy 27. The combination of immunotherapy with in vitro expanded γδ T-lymphocytes and radiotherapy has not been evaluated and is an avenue worth visiting.

Conclusions

Taken together, the results provide no evidence for different radiation sensitivity of γδ lymphocytes, pan T-lymphocytes and total PBMC. This does not exclude the possibility that the often observed difference in radiosensitivity of PBMC between cancer patients and healthy donors results from a different composition of lymphocyte subpopulations.

Methods

Isolation of human peripheral mononuclear cells and T-lymphocytes

Experiments were performed with PBMC isolated from three healthy volunteers: donor 1 (male, aged 49, non-smoker), donor 2 (male, aged 53, non-smoker) and donor 3 (male, aged 40, non-smoker). The study was approved by the local ethical committee. Written informed consent was obtained from the volunteers for publication. A copy of the written consent is available for review by the Editor-in-Chief of this journal. Three independent experiments were performed, each with blood of one donor.

PBMCs were isolated from 80 ml fresh blood on a histopaque gradient. Pan T cells (CD3+, containing both αβ and γδ T-lymphocytes) were isolated from 6 × 10⁶PBMCs that were mixed with pan T-cell isolation beads according to the manufacturers instructions (Miltenyi Biotec Inc., Auburn, CA). T-lymphocytes being CD3+ were negatively selected on a MACS column. 4 × 10⁶PBMCs were kept for further experiments and pan γδ T-cells were purified from the remainder of the PBMCs assuming that 10% were γδ T-cells and adjusting the manufacturers protocol accordingly (Miltenyi Biotec Inc., Auburn, CA). γδ+ cells were positively selected on a MACS column. The cells were counted in trypan blue in a Countess Automatic Cell Counter (Intvitrogen, Carlsbad, CA) and kept at 1 × 10⁶per ml in RPMI medium supplemented with 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin at 37°C in humidified incubator under 5% CO₂and used within twenty hours for the comet assay.

Irradiation and comet assay

Irradiation was carried out using a Scanditronix (Uppsala, Sweden) ¹³⁷Cs source operating at 0.47 Gy/min. Cells were transferred to 1.5 ml Eppendorf cups, placed in 37°C water cups, irradiated with a dose of 1 Gy and immediately placed on ice to stop DNA repair. Following incubation on ice cells were kept at 37°C for 0, 15, 30 and 60 min and processed for the alkaline comet assay 28. Two non-irradiated samples per cell type and experiment were analysed as controls following incubation at 37°C for 0 and 60 min.

Microscope slides were pre-coated with 50 μl of 0.5% normal melting agarose (BDH, Germany), and left to dry. 1.5 × 10⁵cells were mixed 1:1 with low melting agarose (US, Belgium) at 37°C, 100 μl of this suspension was placed on a pre-coated slide, covered with a coverslip and left to solidify at +4°C for 5 min. Thereafter the coverslips were removed and the rest of the assay was conducted at +4°C, to ensure gel stability, using only red light as the light source. The slides were immersed in lysis buffer (2.5 M NaCl, 100 mM Na₂EDTA, 10 mM Tris, 1% Triton X-100, pH 10.0) for 1 hour, followed by a brief washing step in double distilled H₂O for 5 min. The slides were then placed in an EC 340 Maxicell Primo (Thermo EC, Holbrook, USA) electrophoresis tank containing 1.31 L unwinding/electrophoresis buffer (1 mM Na₂EDTA, 300 mM NaOH, pH 13.3). After 1 h of incubation the power supply unit (Kyoritsu P 103B, Tokyo, Japan) was switched on and ran at 32.5 V (1 V/cm), 430 mA for 25 minutes. The number of slides in the unit was constant for all experiments.

Following electrophoresis, slides were washed in neutralization buffer (0.4 M Tris), stained with 1 μM DAPI (in water, Sigma-Aldrich), covered with coverslips and stored in the dark at +4°C in a humid container until analysis the following day. Comets were scored blind using a 40× objective on a Nikon Eclipse E800 (Nikon, Tokyo, Japan) fluorescence microscope. Images were acquired and analyzed using the Comet II software (Perspective Instruments, Suffolk, UK, version 2.11). 50 cells per experiment and point were analysed.

Statistical analysis

The Comet II software yields Excel data sheets with the measurement results for each cell from a treatment group. We focused on analysing % TDNA as the marker of damage. In order to reduce data scatter, the results obtained for each treatment point were processed as follows: the % TDNA values were sorted in raising order and 5 lowest and 5 highest values were deleted. This procedure was carried out for every treatment group including the control samples. Thus, the number of cells analysed was reduced to 40. For the analysis of radiation-induced level of % TDBA, the mean (from 0 and 60 min incubation time) control level of % TDNA was subtracted.

The average values from individual experiments were compared using the 2 tailed Student's t-test.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

AH and MD-K ran the comet assay experiments; IP isolated lymphocytes, participated in the design of the study and in writing the manuscript; SH collected peripheral blood and participated in writing the manuscript; AW participated in the design of the study, in statistical analysis and in writing the manuscript. All authors read and approved the final manuscript.

Acknowledgements

This project was funded by a grant from Johan and Jacob Söderberg's Foundation to IP and by a grant from the Swedish Radiation Protection Authority (SSM) to AW. We are grateful to J. Adler for editorial help.

Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancerHoellerUBorgmannKBonackerMKuhlmeyABajrovicAJungHAlbertiWDikomeyERadiother Oncol20036913714410.1016/j.radonc.2003.10.00114643950Genetic predisposition in breast cancerScottDSpreadboroughALevineERobertsSALancet1994344144410.1016/S0140-6736(94)90615-77968110Chromosomal radiosensitivity as a marker of predisposition to common cancers?BariaKWarrenCRobertsSAWestCMScottDBr J Cancer20018489289610.1054/bjoc.2000.1701236383711286467Chromosomal radiosensitivity in G2-phase lymphocytes identifies breast cancer patients with distinctive tumour characteristicsRichesACBryantPESteelCMBr J Cancer2001851157116110.1054/bjoc.2001.2086237514911710829The use of IL-2 cultures to measure chromosomal radiosensitivity in breast cancer patientsBaeyensAVandenbulckeKPhilippeJThierensHDe RidderLVralAMutagenesis20041949349810.1093/mutage/geh06315548763Chromosomal radiosensitivity in young cancer patients: possible evidence of genetic predispositionBariaKWarrenCEdenOBRobertsSAWestCMScottDInt J Radiat Biol20027834134610.1080/0955300011011735912020425Elevated G2 chromosomal radiosensitivity in Irish breast cancer patients: a comparison with other studiesHoweOLDalyPASeymourCOrmistonWNolanCMothersillCInt J Radiat Biol20058137337810.1080/0955300050014764216076752Enhanced chromosomal radiosensitivity in peripheral blood lymphocytes of larynx cancer patientsLisowskaHLankoffAWieczorekAFlorekAKuszewskiTGóźdźSWojcikAInt J Radiat Oncol Biol Phys2006661245125210.1016/j.ijrobp.2006.07.137017145539Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytesDe RuyckKVan EijkerenMClaesKMorthierRDe PaepeAVralADe RidderLThierensHInt J Radiat Oncol Biol Phys2005621140114910.1016/j.ijrobp.2004.12.02715990020A cytogenetic analysis of the long-term effect of uranium mining on peripheral lymphocytes using the micronucleus-centromere assayKryscioAMüllerW-UWojcikAKotschyNGrobelnySStrefferCInt J Radiat Biol2001771087109310.1080/0955300011007028911683979Radiation sensitivity of lymphocytes from healthy individuals and cancer patients as measured by the comet assayMüllerW-UBauchTStübenGSackHStrefferCRadiat Environ Biophys200140838910.1007/s00411000008711357715Response of lymphocytes to radiation in untreated breast cancer patients as detected with three different genetic assaysLouJLChenZJWeiJHeJLJinLFChenSJZhengWXuSJBiomed Environ Sci20082149950810.1016/S0895-3988(09)60009-X19263806X-ray induction of micronuclei in human lymphocyte subpopulations differentiated by immunoperoxidase stainingBanSCologneJBRadiat Res1992131606510.2307/35783171378225Radiation induced micronuclei in subpopulations of human lymphocytesWuttkeKStrefferCMullerWUMutat Res19932861811887681529A higher micronucleus yield in B-versus T-cells after low-dose gamma-irradiation is not linked with defective Ku86 proteinVralAThierensHBryantPDeRLInt J Radiat Biol20017732933910.1080/095530000100423711258847Intrinsic susceptibility to radiation-induced apoptosis of human lymphocyte subpopulationsSchmitzABayerJDechampsNThomasGInt J Radiat Oncol Biol Phys20035776977810.1016/S0360-3016(03)00637-014529783The effect of the ratio of CD4+ to CD8+ T-cells on radiation-induced apoptosis in human lymphocyte subpopulationsWilkinsRCKutznerBCTruongMMcLeanJRInt J Radiat Biol20027868168810.1080/0955300021014447512194751Changes in peripheral blood lymphocyte subsets in patients undergoing radiotherapyLouagieHVanEMPhilippeJThierensHDeRLInt J Radiat Biol19997576777110.1080/09553009914011310405007Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cellsGoberHJKistowskaMAngmanLJenoPMoriLDeLGJ Exp Med200319716316810.1084/jem.20021500219381412538656Perspectives of gammadelta T cells in tumor immunologyKabelitzDWeschDHeWCancer Res2007675810.1158/0008-5472.CAN-06-306917210676Defective gammadelta T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patientsGaafarAAljurfMDAl-SulaimanAIqniebiAManogaranPSMohamedGEAl-SayedAAlzahraniHAlsharifFMoharebFAjarimDTabakhiAAl-HusseinKExp Hematol20093783884810.1016/j.exphem.2009.04.00319446661Phenotypic and functional alterations of Vgamma2Vdelta2 T cell subsets in patients with active nasopharyngeal carcinomaPuanKJLowJSTanTWWeeJTTanEHFongKWChuaETJinCGinerJLMoritaCTGohCHHuiKMCancer Immunol Immunother2009581095110710.1007/s00262-008-0629-8269587519043708Gammadelta T cells for immune therapy of patients with lymphoid malignanciesWilhelmMKunzmannVEcksteinSReimerPWeissingerFRuedigerTTonyHPBlood200310220020610.1182/blood-2002-12-366512623838The comet assay: topical issuesCollinsAROscozAABrunborgGGaivãoIGiovannelliLKruszewskiMSmithCCStetinaRMutagenesis20082314315110.1093/mutage/gem05118283046Radiation induced micronuclei in subpopulations of human lymphocytesWuttkeKStrefferCMüllerWUMutat Res199328618118887681529Antitumor activity of gammadelta T cells reactive against cytomegalovirus-infected cells in a mouse xenograft tumor modelDevaudCBilhereELoizonSPitardVBehrCMoreauJFDechanet-MervilleJCaponeMCancer Res2009693971397810.1158/0008-5472.CAN-08-303719383918In vivo effects of zoledronic acid on peripheral gammadelta T-lymphocytes in early breast cancer patientsSantiniDMartiniFFrattoMEGalluzzoSVincenziBAgratiCTurchiFPiacentiniPRocciLManavalanJSToniniGPocciaFCancer Immunol Immunother200958313810.1007/s00262-008-0521-618458903A microgel electrophoresis technique for the direct quantitation of DNA damage and repair in individual fibroblasts cultured on microscope slidesSinghNPTiceRRStephensenRESchneiderEMutat Res19912522892962052008